Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

ADP-ribosylation signalling and human disease

PARP10 3,4-dihydroisoquinolin-1(2H)-one (dq)-based inhibitors

Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo

PDF] Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.

Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes - Tim J. Wigle, W. David Church, Christina R. Majer, Kerren K. Swinger, Demet Aybar, Laurie B. Schenkel, Melissa M. Vasbinder, Arne

MacroGreen, a simple tool for detection of ADP-ribosylated proteins

Identification of Protein Substrates of Specific PARP Enzymes Using Analog-Sensitive PARP Mutants and a Clickable NAD+ Analog. - Abstract - Europe PMC

PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools - ScienceDirect

Poly(ADP-Ribosylation) in Age-Related Neurological Disease: Trends in Genetics

Molecules, Free Full-Text

Frontiers Virus–Host Interplay Between Poly (ADP-Ribose) Polymerase 1 and Oncogenic Gammaherpesviruses